TennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 7 Sponsors

Mar 10, 2026 · House

Assigned to General Subcommittee of Senate Commerce and Labor Committee

Mar 5, 2026 · Senate

Passed on Second Consideration, refer to Senate Commerce and Labor Committee

Mar 4, 2026 · House

Placed on Senate Commerce and Labor Committee calendar for 3/10/2026

Mar 2, 2026 · House

Approved by Delayed Bills Committee

Mar 2, 2026 · House

Introduced, Passed on First Consideration

Feb 2, 2026 · House

Refer to Senate Delayed Bills Committee

Feb 2, 2026 · House

Filed for introduction

PASSAGE PROBABILITY

24.4% Unlikely

Why this number

Stage base In Committee — base rate 51%, measured from TN's completed sessions
Momentum -5 29/100 from the pace of recorded action
Time since last action -22 219 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.